Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines

Published:2019-11-30 Issue:12 Volume:97 Page:1685-1694
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Hu Zhidong,Jiang Weimin,Gu Ling,Qiao Dan,Shu Tsugumine,Lowrie Douglas B.,Lu Shui-Hua,Fan Xiao-Yong

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00109-019-01844-3.pdf

Reference50 articles.

1. World Health Organization, Global tuberculosis report (2018) http://apps.who.int/medicinedocs/en/m/abstract/Js23553en/

2. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698–702

3. Jasenosky LD, Scriba TJ, Hanekom WA, Goldfeld AE (2015) T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev 264:74–87

4. Lewinsohn DA, Lewinsohn DM, Scriba TJ (2017) Polyfunctional CD4(+) T cells as targets for tuberculosis vaccination. Front Immunol 8:1262

5. Ernst JD (2018) Mechanisms of M. tuberculosis immune evasion as challenges to TB vaccine design. Cell Host Microbe 24:34–42

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis;Emerging Microbes & Infections;2024-01-04

2. Comparison of heterologous prime-boost immunization strategies with DNA and recombinant vaccinia virus co-expressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus in pigs;Microbial Pathogenesis;2023-10

3. The Use of Particulate Systems for Tuberculosis Prophylaxis and Treatment: Opportunities and Challenges;Microorganisms;2023-08-02

4. Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen;Tuberculosis;2023-01

5. Tuberculosis control by novel vaccines development and Indian initiatives;MGM Journal of Medical Sciences;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3